Nachrichten zur Johnson & Johnson Aktie

Is Johnson & Johnson a Buy After Its Q1 2026 Earnings Report?

Solid results werent impressive enough to move the stock price higher.…

US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims

US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims…

MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)

LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic…

Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson: Ausblick leicht angehoben

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

Johnson & Johnson (JNJ) Q1 2026 Earnings Call Transcript

…

ROUNDUP: Krebsmedikamente treiben Johnson & Johnson - Quartal überraschend stark

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson hat auch zum Jahresstart die Umsatzeinbußen…

Johnson & Johnson’s Spravato sales growth signals upside for psychedelics peers like AtaiBeckley

Johnson & Johnson (NYSE:JNJ)’s Spravato is reinforcing investor interest in the broader psychedelics sector as it reported another quarter of…

Krebsmedikamente treiben Johnson & Johnson - Erstes Quartal überraschend stark

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson hat auch zum Jahresstart die Umsatzeinbußen…

J&Js first-quarter profit beats estimates even as Stelara sales disappoint

Johnson & Johnson reported first-quarter earnings that beat Wall Street expectations on Tuesday and raised its full-year forecast, as strong…

Johnson & Johnson beats quarterly revenue estimates, maintains full-year outlook

Johnson & Johnson (NYSE:JNJ) reported first-quarter results on Tuesday that beat Wall Street expectations for revenue, driven by solid growth…

1 Stock to Buy, 1 Stock to Sell This Week: Netflix, Johnson & Johnson

Market Analysis by covering: SPDR® S&P 500® ETF Trust, Invesco QQQ Trust, Johnson & Johnson, Netflix Inc. Read s…

The $100 Billion Pivot: Why Johnson & Johnson Is My Top Dividend King to Buy in 2026

This stock might help you sleep more easily at night.…

Johnson Outdoors Is A Valid Turnaround Play (Upgrade)

…

HURA: 2025 Financial Results

By John Vandermosten, CFANASDAQ: HURAREAD THE FULL HURA RESEARCH REPORTOperational and Financial ResultsOn April 1st, 2026, TuHURA Biosciences, Inc. (NASDAQ:…

Gear Up for Johnson & Johnson (JNJ) Q1 Earnings: Wall Street Estimates for Key Metrics

Besides Wall Streets top-and-bottom-line estimates for Johnson & Johnson (JNJ), review projections for some of its key metrics to gain…

Johnson & Johnson Aktie: Kaufchance! Beginnt jetzt die nächste Wachstumsphase?

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Goldman Sachs:Goldman Sachs bestätige vor den Ergebnissen zum ersten Quartal das "buy"-Votum…

Johnson & Johnson Aktie: Höheres Kursziel trotz Branchenunsicherheit

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Citi:Die Analysten von Citi haben das Kursziel für die Aktie von Johnson…

Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know

Johnson & Johnson (JNJ) closed at $241.3 in the latest trading session, marking a +1.21% move from the prior day.…

Heres What Could Help Johnson Outdoor (JOUT) Maintain Its Recent Price Strength

If you are looking for stocks that are well positioned to maintain their recent uptrend, Johnson Outdoor (JOUT) could be…

Johnson & Johnson: Success In Multiple Myeloma Underpins $25B In Growth By 2030

…

Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing

Johnson & Johnson (JNJ) closed the most recent trading day at $239.93, moving +1.98% from the previous trading session.…

Darum ist der Gesundheitsgigant Johnson & Johnson mein unangefochtener Favorit im Pharmasektor!

Wenn es um erstklassige Investments im Gesundheitssektor geht, führt für mich aktuell kein Weg an Johnson & Johnson (i)(JNJ) vorbei.…

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Johnson & Johnson said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to…

The Zacks Analyst Blog JPMorgan, Johnson & Johnson, Applied Materials and Value Line

JPMorgan, Johnson & Johnson and Applied Materials stand out in new research reports, highlighting strong business momentum despite industry and…

JNJ Seeks Label Expansion of Multiple Myeloma Drug Tecvayli in the EU

Johnson & Johnson seeks EMA nod to expand Tecvayli monotherapy use in earlier-line RRMM, backed by phase III MajesTEC-9 data…

Johnson & Johnson Aktie: Medizintechnik-Sektor weiter in starker Verfassung

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Citigroup:Citi habe das Kursziel für die Aktie von Johnson & Johnson (J&J)…

Johnson Service Group PLC (JSVGF) Q4 2025 Earnings Call Prepared Remarks Transcript

…

Stockpickers: London Stock Exchange, Johnson Service Group, Greggs

Our experts discuss which companies to buy, sell or hold this week…

Scherbaums Börse: Die Stärke von Johnson & Johnson

Donald Trump zwingt Pharmakonzerne zu Preisnachlässen. Doch ausgerechnet Johnson & Johnson liefert überraschend starke Zahlen. Anleger stellen sich nun eine…

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $239.63, denoting a -2.31% move from…

Johnson & Johnson launches website for direct-to-consumer sales

Johnson & Johnson has launched a website to sell some of its drugs directly to U.S. patients who either dont…

Johnson & Johnson launches website for direct-to-consumer sales

Johnson & Johnson launches website for direct-to-consumer sales…

Cryoport (CYRX) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.DATETuesday, March 3, 2026 at 5 p.m. ETCALL PARTICIPANTSChief Executive Officer — Jerrell SheltonChief Financial Officer…

Johnson & Johnson Aktie: BofA sieht mehr Umsatzpotenzial - Fokus auf Tecvayli und Inlexzo

Charlotte (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von BofA Securities:Jason Gerberry, Analyst von BofA Securities, stuft die Aktie von Johnson &…

5 stocks winning the rotation in 2026

Transcript: Caroline WoodsBig tech has dominated portfolios for years, but David Johnsons top stock picks right now dont include a…

Johnson Service Group efficiency improves margins and profit

Johnson Service Group (LON: JSG) has shown its ability to grow despite the weak consumer market hitting its core customer…

Johnson & Johnson (JNJ) Advances While Market Declines: Some Information for Investors

Johnson & Johnson (JNJ) closed the most recent trading day at $248.43, moving +2.04% from the previous trading session.…

Johnson Outdoors Announces Cash Dividend

RACINE, Wis., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq: JOUT), a leading global innovator of…

DENTSPLY SIRONA (XRAY) Q4 2025 Earnings Transcript

Image source: The Motley Fool.DATEThursday, Feb. 26, 2026 at 4:30 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Daniel T.…

TopBuild Expands Texas Footprint With Johnson Roofing Acquisition

BLD expands in Texas with the Johnson Roofing buy, boosting its commercial roofing platform and regional scale as shares edge…

Federal Signal (FSS) Q4 2025 Earnings Transcript

Image source: The Motley Fool.DateFeb. 25, 202610 a.m. ETCall participantsPresident & Chief Executive Officer — Jennifer L. ShermanVice President &…

Bayer verklagt Johnson & Johnson – Aktie fällt und fällt

Der DAX-Konzern Bayer will sich in den Vereinigten Staaten juristisch gegen Johnson & Johnson wehren. Der Hintergrund für die Klage…

Bayer verklagt Johnson & Johnson – Aktie fällt und fällt

Der DAX-Konzern Bayer will sich in den Vereinigten Staaten juristisch gegen Johnson & Johnson wehren. Der Hintergrund für die Klage…

TopBuild to Acquire Johnson Roofing

DAYTONA BEACH, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD), a leading installer of insulation and…

Bayer verklagt Johnson & Johnson wegen irreführender Werbung

Von Nicholas G. Miller DOW JONES--Die Bayer AG verklagt Johnson Johnson (JJ) und deren Sparte Janssen Biotech wegen…

CYCN: Positive Feedback from FDA Sets Stage for Phase 2 Trial of CYC-126 in 2H26

By David Bautz, PhDNASDAQ:CYCNREAD THE FULL CYCN RESEARCH REPORTBusiness UpdatePositive Regulatory Feedback Supports Phase 2 Trial Initiation in 2H26On February…

Johnson & Johnson vs. AbbVie: A Growth Showdown Amid Patent Cliffs

JNJs diversified model, $32B R&D push and 48% stock surge in a year raise the stakes in its battle with…